Hygiène Hospitalière, Centre Hospitalier Régional Universitaire, Besançon, France.
Centre de Ressources Biologiques Filière Microbiologique de Besançon, Centre Hospitalier Régional Universitaire, Besançon, France.
PLoS One. 2018 Oct 11;13(10):e0205603. doi: 10.1371/journal.pone.0205603. eCollection 2018.
Antibiotic resistance is a major public health problem requiring the early optimization of antibiotic prescriptions. Matrix-Assisted Laser Desorption Ionization-Time Of Flight Mass Spectrometry (MALDI-TOF MS) has been shown to accurately identify bacteria from positive blood culture. Here, we developed a rapid detection of Escherichia coli resistance to amoxicillin (AMX) and cefotaxime (CTX) from positive blood culture based on MALDI-TOF MS. Potential sparing of broad-spectrum antibiotics was also evaluated. We tested 103 E. coli-positive blood cultures. Blood cultures were subculture 1-hour in antibiotic-free rich liquid media before further incubation with and without AMX for 2.5 h or CTX for 2 h. Protein extracts associated with an internal control were spotted on a MALDI-TOF target and spectra were analyzed with the MBT-ASTRA prototype software (Bruker Daltonik GmbH, Bremen, Germany). Bacterial growth ratio was calculated from the AUC spectra obtained in the presence and absence of the antibiotic and compared to a threshold which classified E. coli as susceptible or resistant. Results were interpreted with MICs determined using agar dilution method as reference technique. MBT-ASTRA recognized 95% and 84% of the AMX- and CTX-susceptible isolates, respectively. Overall, quantitative analysis of mass spectra allows susceptibility testing within 4 hours after the positivity of blood culture with E. coli. At the first report of positive blood culture, MALDI-TOF MS would then provide the prescribers with the bacterial identification and the susceptibility to AMX and CTX, thus limiting the use of broad-spectrum compounds.
抗生素耐药性是一个重大的公共卫生问题,需要尽早优化抗生素处方。基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)已被证明可准确鉴定阳性血培养中的细菌。在此,我们基于 MALDI-TOF MS 开发了一种从阳性血培养中快速检测大肠埃希菌对阿莫西林(AMX)和头孢噻肟(CTX)耐药性的方法。还评估了潜在的广谱抗生素节约。我们测试了 103 例大肠埃希菌阳性血培养物。血培养在无抗生素的富液体培养基中孵育 1 小时,然后进一步孵育 2.5 小时加 AMX 或 2 小时加 CTX。将与内部对照相关的蛋白质提取物点在 MALDI-TOF 靶标上,并使用 MBT-ASTRA 原型软件(Bruker Daltonik GmbH,不来梅,德国)分析光谱。根据有无抗生素获得的 AUC 光谱计算细菌生长比,并与将大肠埃希菌分类为敏感或耐药的阈值进行比较。结果使用琼脂稀释法确定 MIC 作为参考技术进行解释。MBT-ASTRA 分别识别 95%和 84%的 AMX 和 CTX 敏感分离株。总体而言,在血培养阳性后 4 小时内,通过质谱的定量分析可进行药敏试验。在首次报告阳性血培养时,MALDI-TOF MS 将为医生提供细菌鉴定以及对 AMX 和 CTX 的药敏性,从而限制广谱化合物的使用。